结肠癌形态学特征结合错配修复蛋白免疫组化表达的诊断价值
DOI:
CSTR:
作者:
作者单位:

郑州金域临床检验中心有限公司

作者简介:

通讯作者:

中图分类号:

基金项目:


The diagnostic value of the morphological characteristics of colon cancer combined with the immunohistochemical expression of mismatch repair proteins
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨结肠癌形态学特征及错配修复蛋白免疫组化表达与临床病理分期的关系,评估二者联合对晚期结肠癌的诊断价值。方法 选取2022年2月至2025年10月期间本院接收的根治性手术切除的100例结肠癌患者的临床资料。统计患者的组织病理学分期结果,并按照病理诊断结果将患者分为早期组(Ⅰ-Ⅱ期,52例)、晚期组(III-IV期,48例)。统计并比较两组的形态学特征及错配修复蛋白免疫组化表达结果。分析形态学特征与分期的关系,评估形态学特征结合错配修复状态对结肠癌分期的诊断效能。结果 晚期组的低分化癌、高级别肿瘤出芽、脉管侵犯占比均显著高于早期组(P<0.05)。晚期组的MSH6蛋白缺失占比显著高于早期组(P<0.05)。Logistic回归分析显示,结肠癌分期与低分化、高级别肿瘤出芽、脉管侵犯、MSH6蛋白缺失有关(P<0.05),得到回归模型:Lβ(Y)=-1.895+1.803×分化程度+1.781×肿瘤出芽级别+1.678×脉管侵犯+1.735×MSH6缺失。ROC曲线分析显示,低分化癌、高级别肿瘤出芽、脉管侵犯及MSH6缺失结合构成的回归模型鉴别Ⅲ-Ⅳ级病理改变的AUC为0.851(95%CI:0.770-0.932),特异度、灵敏度、约登指数分别为:0.731、0.958、0.689,有较高的诊断价值。结论 低分化、高级别肿瘤出芽、脉管侵犯及MSH6蛋白缺失与结肠癌晚期病理分期密切相关,联合检测能辅助常规病理检查,为分期判定提供参考。

    Abstract:

    Objective To explore the relationship between the morphological characteristics of colon cancer and the immunohistochemical expression of mismatch repair proteins and the clinicopathological stage, and to evaluate the diagnostic value of the combination of the two for advanced colon cancer. Methods: The clinical data of 100 patients with colon cancer who underwent radical surgical resection in our hospital from February 2022 to October 2025 were selected. The histopathological staging results of the patients were statistically analyzed, and the patients were divided into the early group (stage I-II, 52 cases) and the late group (stage III-IV, 48 cases) according to the pathological diagnosis results. The morphological characteristics and immunohistochemical expression results of mismatch repair proteins of the two groups were statistically analyzed and compared. Analyze the relationship between morphological features and staging, and evaluate the diagnostic efficacy of morphological features combined with mismatch repair status for the staging of colon cancer. Results: The proportions of poorly differentiated carcinoma, high-grade tumor budding, and vascular invasion in the advanced group were significantly higher than those in the early group (P < 0.05). The proportion of MSH6 protein deficiency in the advanced group was significantly higher than that in the early group (P < 0.05). Logistic regression analysis showed that the stage of colon cancer was related to low differentiation, high-grade tumor budding, vascular invasion, and MSH6 protein deficiency (P < 0.05), and the regression model was obtained: Lβ (Y) =-1.895+1.803× degree of differentiation +1.781× tumor budding grade +1.678× vascular invasion +1.735×MSH6 deletion. ROC curve analysis showed that the AUC of the regression model composed of poorly differentiated carcinoma, high-grade tumor budding, vascular invasion and MSH6 deletion in differentiating grade III-IV pathological changes was 0.851 (95%CI: 0.770-0.932), and the specificity, sensitivity and Youden index were respectively: 0.731, 0.958, and 0.689 have relatively high diagnostic value. Conclusion: Poorly differentiated, high-grade tumor budding, vascular invasion and MSH6 protein deficiency are closely related to the pathological stage of advanced colon cancer. Combined detection can assist routine pathological examination and provide a reference for stage determination.

    参考文献
    相似文献
    引证文献
引用本文
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2026-02-24
  • 最后修改日期:2026-05-09
  • 录用日期:2026-06-08
  • 在线发布日期:
  • 出版日期:
文章二维码